2017-03-21,Neurocrine Announces American Journal Of Psychiatry Publication Of Positive Results From Kinect 3 Phase III Study Of INGREZZA TM (valbenazine) For The Treatment Of Tardive Dyskinesia
2017-02-09,Neurocrine And BIAL Announce Exclusive North American Licensing Agreement For Opicapone
2017-02-07,Neurocrine Biosciences Announces Conference Call And Webcast To Report Fourth Quarter And Year-End 2016 Results
2017-01-27,Premarket Biotech Movers: Neurocrine Biosciences, Aralez Pharmaceuticals, Qiagen
2017-01-27,Analysts' Actions -- Ford, Intel, Whirlpool, Wynn and More
2017-01-17,Neurocrine Drug Fails to Reduce Tic Severity in Tourette Syndrome Patients
2017-01-17,Neurocrine Announces Completion Of Phase II Clinical Study Of VMAT2 Inhibitor INGREZZA™ (valbenazine) In Adults With Tourette Syndrome
2017-01-06,Neurocrine Biosciences Announces The Appointment Of David-Alexandre Gros M.D. President And Chief Operating Officer
2017-01-05,Neurocrine Provides Update On FDA Advisory Committee For INGREZZA™ (valbenazine) For The Treatment Of Tardive Dyskinesia
2017-01-03,Neurocrine Biosciences To Present At The 35th Annual J.P. Morgan Healthcare Conference
2017-01-03,17 Thoughts on Biotech Stocks to Kick Off 2017
2016-12-21,Neurocrine Biosciences Announces Chief Financial Officer Timothy P. Coughlin To Step Down
2016-12-07,Neurocrine Biosciences To Present At The 2016 BMO Capital Markets Prescription For Success Healthcare Conference
2016-12-05,Neurocrine Biosciences Announces INGREZZA™ (valbenazine) Long-Term Data To Be Presented At The 55th Annual Meeting Of The American College Of Neuropsychopharmacology
2016-11-29,Neurocrine Announces FDA Advisory Committee Meeting To Review INGREZZA™ (valbenazine) New Drug Application For The Treatment Of Tardive Dyskinesia
2016-11-21,Neurocrine Biosciences To Present At The 28th Annual Piper Jaffray Healthcare Conference
2016-11-10,Neurocrine Biosciences To Present At The Jefferies 2016 London Healthcare Conference
2016-10-31,Neurocrine Biosciences To Present At The Credit Suisse 25th Annual Healthcare Conference
2016-10-31,Research Reports Coverage On Generic Drugs Stocks -- Evoke Pharma, Catalyst Pharma, Neurocrine Biosciences, And Galectin Therapeutics
2016-10-26,Neurocrine Biosciences Announces Conference Call And Webcast To Report Third Quarter 2016 Results
2016-10-19,AbbVie Announces Positive Pivotal Phase 3 Data Demonstrating Investigational Medicine Elagolix Reduces Menstrual And Non-Menstrual Pelvic Pain Associated With Endometriosis At The American Society For Reproductive Medicine Scientific Congress
2016-10-11,Neurocrine Announces INGREZZA™ (valbenazine) New Drug Application For The Treatment Of Tardive Dyskinesia Has Been Accepted For Priority Review By U.S. FDA
2016-09-14,These 5 Biotech Stocks Are Ready for a Volatility Break
2016-09-07,Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
2016-09-01,Neurocrine Biosciences to Present at the Baird 2016 Healthcare Conference
2016-08-31,Neurocrine Announces FDA Conditional Acceptance of Proprietary Name INGREZZA™ for VMAT2 Inhibitor Valbenazine
2016-08-29,Neurocrine Submits New Drug Application for Valbenazine for Treatment of Tardive Dyskinesia
2016-07-28,Neurocrine Announces Initiation Of A Long-Term Phase II Clinical Study Of VMAT2 Inhibitor Valbenazine In Tourette Syndrome
2016-07-27,Short Interest In Neurocrine Biosciences Jumps 14%
2016-07-27,Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2016 Results
2016-07-22,Bearish Bets: Biotech, Energy and Other Stocks that Look Good to Short
2016-07-22,Biogen Should Either a Buyer or a Seller Be
2016-07-15,Ratings Changes Today
2016-07-13,Short Interest In Neurocrine Biosciences Decreases By 30%
2016-06-02,Neurocrine Biosciences To Present At The Jefferies 2016 Healthcare Conference
2016-05-31,Neurocrine Biosciences (NBIX) Strong On High Relative Volume Today
2016-05-27,Insider Trading Alert - NBIX, FRGI And LBAI Traded By Insiders
2016-05-23,Xenoport's Cost-Cutting Tactics Lead to Buyout With Hefty Premium
2016-05-20,Neurocrine Biosciences Announces The Retirement Of W. Thomas Mitchell From The Board Of Directors
2016-05-18,Strong On High Volume: Neurocrine Biosciences (NBIX)
2016-05-12,Short Interest Moves 11% Higher For NBIX
2016-05-06,Neurocrine Biosciences To Present At The Bank Of America Merrill Lynch 2016 Health Care Conference
2016-05-06,Neurocrine Biosciences Announces Additional Valbenazine (NBI-98854) Data To Be Presented At The American Psychiatric Association's 2016 Annual Meeting In Atlanta
2016-04-29,Neurocrine Biosciences Announces Conference Call And Webcast To Report First Quarter 2016 Results
2016-04-27,Neurocrine Biosciences To Present At The Deutsche Bank 41st Annual Health Care Conference
2016-04-08,'Mad Money' Lightning Round: I'm Taking Starbucks Over Bojangles
2016-04-07,Jim Cramer's 'Mad Money' Recap: Uncle Sam, Back Off Business!
2016-04-07,Neurocrine Biosciences (NBIX) Stock Gets &lsquo;Outperform&rsquo; Rating at BMO Capital
2016-03-09,Neurocrine Biosciences To Present At The Barclays Global Healthcare Conference
2016-03-02,Neurocrine Biosciences To Present At The Cowen And Company 36th Annual Health Care Conference
2016-03-02,Neurocrine Biosciences Announces The Acceptance Of Three Scientific Abstracts For Valbenazine (NBI-98854) At The 68th Annual Meeting Of The American Academy Of Neurology In Vancouver April 2016
2016-02-08,Neurocrine Biosciences Announces Conference Call And Webcast To Report Fourth Quarter And Year-End 2015 Results
2016-02-03,Neurocrine Biosciences To Present At The Leerink Partners 5th Annual Global Healthcare Conference
2016-02-02,Neurocrine Announces Initiation Of Phase II Clinical Study Of VMAT2 Inhibitor Valbenazine In Children And Adolescents With Tourette Syndrome
2016-01-28,AbbVie Initiates Enrollment In Phase 3 Clinical Program For Elagolix In Patients With Uterine Fibroids
2016-01-04,Neurocrine Biosciences To Present At The 34th Annual J.P. Morgan Healthcare Conference
2015-12-16,Neurocrine Announces Successful Completion Of Phase Ib T-Force Study Of VMAT2 Inhibitor NBI-98854 In Adolescents And Children With Tourette Syndrome
2015-12-08,J.P. Morgan's 53 Top Stock Picks for 2016
2015-11-25,Neurocrine Biosciences To Present At The 27th Annual Piper Jaffray Healthcare Conference
2015-11-21,JPMorgan Likes These 5 Biotech Stocks
2015-11-11,Neurocrine Biosciences To Present At The Jefferies Autumn 2015 Global Healthcare Conference
2015-11-04,Neurocrine Biosciences To Present At Credit Suisse's 24th Annual Healthcare Conference
2015-11-04,Neurocrine Biosciences Announces Expansion Of Its Clinical Pipeline
2015-10-22,Neurocrine Biosciences Announces Conference Call And Webcast To Report Third Quarter 2015 Results
2015-10-20,Insider Trading Alert - NBIX, HELE And FB Traded By Insiders
2015-10-20,Neurocrine Announces Initiation Of Phase II Clinical Study Of VMAT2 Inhibitor NBI-98854 In Adults With Tourette Syndrome
2015-10-09,Perilous Reversal Stock: Neurocrine Biosciences (NBIX)
2015-10-08,Neurocrine Biosciences (NBIX) Stock Spikes on Positive Phase 3 Results
2015-10-08,Pre-Market Activity Shows Heavy Volume And Movement For Neurocrine Biosciences (NBIX)
2015-10-01,Neurocrine Biosciences (NBIX) Showing Signs Of Perilous Reversal Today
2015-09-30,Neurocrine Biosciences Announces The Appointment Of George J. Morrow To Its Board Of Directors
2015-09-30,Strong On High Volume: Neurocrine Biosciences (NBIX)
2015-09-22,Insider Trading Alert - NBIX, TPLM And HURC Traded By Insiders
2015-09-21,Neurocrine Biosciences (NBIX) Showing Signs Of Being Water-Logged And Getting Wetter
2015-09-16,AbbVie Announces Plans To Proceed To Phase 3 Evaluation Of Elagolix In Patients With Uterine Fibroids
2015-09-10,Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
2015-09-10,Trade-Ideas: Neurocrine Biosciences (NBIX) Is Today's Strong On High Relative Volume Stock
2015-09-03,Neurocrine Biosciences Announces The Appointment Of Dr. Alfred W. Sandrock To Its Board Of Directors
2015-09-02,Neurocrine Biosciences To Present At The Baird 2015 Healthcare Conference
2015-08-13,Neurocrine Announces Completion Of Enrollment Into Kinect 3 Tardive Dyskinesia Study
2015-07-27,Biogen's Possible Takeout Targets and Other Key Questions After Blow-Up
2015-07-22,Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2015 Results
2015-07-20,Water-Logged And Getting Wetter Stock Of The Day: Neurocrine Biosciences (NBIX)
2015-06-08,Neurocrine Biosciences Provides Update On NBI-77860 Program For Congenital Adrenal Hyperplasia
2015-06-02,Neurocrine Biosciences, Inc. Announces Appointment Of Eric Benevich As Chief Commercial Officer
2015-05-27,Neurocrine Biosciences To Present At The Jefferies 2015 Healthcare Conference
2015-05-18,Ratings Changes Today
2015-05-14,Neurocrine Biosciences (NBIX) Highlighted As Today's Perilous Reversal Stock
2015-05-12,Neurocrine Biosciences To Host Analyst And Investor Day In New York City On May 21, 2015
2015-05-08,Neurocrine Biosciences To Present At The Bank Of America Merrill Lynch 2015 Health Care Conference
2015-05-04,Neurocrine Biosciences, Inc. Announces Appointment Of Dr. Bill Aurora As Vice President, Medical Affairs
2015-04-30,Neurocrine Biosciences To Present At The Deutsche Bank 40th Annual Health Care Conference
2015-04-23,Neurocrine Biosciences Announces Conference Call And Webcast To Report First Quarter 2015 Results
2015-04-23,First Week Of NBIX June 19th Options Trading
2015-03-31,Neurocrine Biosciences And Mitsubishi Tanabe Pharma Announce Agreement To Develop And Commercialize VMAT2 Inhibitor NBI-98854 For Movement Disorders In Japan And Other Select Asian Markets
2015-03-31,'Mad Money' Lightning Round: Alcoa Is Doing Everything Right
2015-03-30,Jim Cramer's 'Mad Money' Recap: Good Headlines Make All the Difference
2015-03-11,Short Interest In Neurocrine Biosciences Drops 20.6%
2015-03-03,Neurocrine Biosciences To Present At The Barclays Global Healthcare Conference Live Audio Webcast Will Be On March 10, 2015
2015-02-24,Neurocrine Biosciences To Present At Cowen And Company's 35th Annual Health Care Conference
2015-02-20,Neurocrine Biosciences, Inc. Announces Exercise In Full Of Underwriters' Option To Purchase Additional Shares
2015-02-19,Neurocrine Biosciences, Inc. Prices Public Offering Of Common Stock
2015-02-17,Neurocrine Biosciences, Inc. Announces Proposed Public Offering Of $225 Million Of Common Stock
2015-02-04,Neurocrine Biosciences To Present At The 2015 Leerink Global Healthcare Conference
2015-02-02,Neurocrine Biosciences Announces Conference Call And Webcast To Report Fourth Quarter And Year-End 2014 Results
2015-01-20,Neurocrine Biosciences Announces Oral Presentation Of NBI-77860 Clinical Trial Data In Classic Congenital Adrenal Hyperplasia At ENDO 2015
2015-01-16,Neurocrine Biosciences Announces Granting Of Orphan Drug Status For NBI-77860 In Congenital Adrenal Hyperplasia
2015-01-09,Biotech Investors' Guide and Preview to J.P. Morgan Healthcare Conference: Part 2
2015-01-08,Neurocrine Biosciences To Present At The 33rd Annual J.P. Morgan Healthcare Conference
2015-01-08,AbbVie Announces Positive Top-Line Results From Phase 3 Study Of Investigational Medicine Elagolix In Patients With Endometriosis
2014-12-24,Commit To Buy Neurocrine Biosciences At $17, Earn 30.2% Annualized Using Options
2014-12-17,2015 Biotech Drug/Stock Outlook: Here's What You Need to Know
2014-12-16,Auspex Drug Reduces Uncontrolled Movements in Huntington's Patients
2014-12-10,Neurocrine Biosciences Announces Expansion Of Its Clinical Pipeline
2014-12-04,Neurocrine Biosciences To Present At The 25th Annual Oppenheimer Healthcare Conference
2014-11-25,Neurocrine To Present At The 2014 Deutsche Bank BioFEST And The 26th Annual Piper Jaffray Healthcare Conference
2014-11-12,Neurocrine Biosciences to Present at the Jefferies 2014 Global Healthcare Conference
2014-11-04,Neurocrine Biosciences, Inc. Announces Appointment Of Darin Lippoldt As Chief Legal Officer
2014-11-03,Neurocrine Biosciences To Present At The Nomura Biotechnology Conference
2014-10-30,Neurocrine Biosciences Receives Breakthrough Therapy Designation For NBI-98854 In Tardive Dyskinesia
2014-10-27,Neurocrine Biosciences Announces Conference Call And Webcast To Report Third Quarter 2014 Financial Results
2014-10-20,Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854
2014-10-02,Neurocrine Announces Expansion Of VMAT2 Inhibitor Program With Initiation Of Tourette Syndrome Clinical Study
2014-10-01,Neurocrine Biosciences, Inc. Announces Appointment Of Malcolm Lloyd-Smith As Chief Regulatory Officer
2014-09-25,2 Big-Volume Biotech Stocks to Trade for Breakouts
2014-09-03,Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
2014-08-26,The Best Hedge Fund You've Never Heard Of and Its Top 5 Stock Picks
2014-08-06,NBIX Crosses Above Key Moving Average Level
2014-07-29,Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
2014-07-08,Commit To Purchase Neurocrine Biosciences At $12, Earn 27.6% Annualized Using Options
2014-06-11,Neurocrine Biosciences Presenting NBI-98854 Scientific Abstracts And Posters At The International Parkinson And Movement Disorder Society's 18th Annual Congress
2014-05-29,Neurocrine Biosciences To Present At The Jefferies 2014 Global Healthcare Conference
2014-05-08,Neurocrine Biosciences To Present At The Bank Of America Merrill Lynch 2014 Health Care Conference
2014-05-08,Bullish Two Hundred Day Moving Average Cross - NBIX
2014-05-01,Neurocrine Biosciences To Present At Deutsche Bank's 39th Annual Health Care Conference
2014-04-25,Neurocrine Biosciences Announces Conference Call And Webcast To Report First Quarter 2014 Financial Results
2014-04-16,Neurocrine Biosciences Inc. Stock Downgraded (NBIX)
2014-04-15,Ratings Changes Today
2014-04-11,Neurocrine Biosciences is Now Oversold (NBIX)
2014-04-07,Commit To Purchase Neurocrine Biosciences At $11, Earn 23.9% Annualized Using Options
2014-03-04,Neurocrine Biosciences To Present At The 26th Annual Roth Conference
2014-02-27,Neurocrine Biosciences To Present At The Cowen And Company 34th Annual Health Care Conference
2014-02-27,Heavy Trading On Neurocrine Biosciences (NBIX) Before Market Open
2014-02-26,Neurocrine Biosciences, Inc. Prices Public Offering Of Common Stock
2014-02-25,Neurocrine Biosciences, Inc. Announces Proposed Public Offering Of Common Stock
2014-02-25,Neurocrine Biosciences Announces NBI-98854 Scientific Presentations At The International Parkinson And Movement Disorder Society's 18th Annual Congress
2014-02-24,Multiple Sectors Punch Market to New Highs
2014-02-07,Neurocrine Biosciences To Present At The Leerink Global Healthcare Conference
2014-02-04,Neurocrine Biosciences Announces Conference Call And Webcast To Report Fourth Quarter And Year-End 2013 Financial Results
2014-01-21,It's Hard to Believe, but Biotech Stocks Are Starting 2014 Hotter Than 2013
2014-01-14,Insider Trading Alert - NDSN, FNSR, NUVA, DECK And NBIX Traded By Insiders
2014-01-14,Insider Trading Alert - NDSN, FNSR, NUVA, DECK And NBIX Traded By Insiders
2014-01-09,Neurocrine Announces 12-Week Safety Results From Initial Phase IIB Study Of VMAT2 Inhibitor NBI-98854
2014-01-09,Biotech Trading 2014 Starts Hot, But Surprise, Last Year Was Even Better
2014-01-09,Insider Trading Alert - SWI, ADBE, GLUU, NBIX And AXE Traded By Insiders
2014-01-09,Insider Trading Alert - SWI, ADBE, GLUU, NBIX And AXE Traded By Insiders
2014-01-08,Trade-Ideas: Neurocrine Biosciences (NBIX) Is Today's "Perilous Reversal" Stock
2014-01-07,Why Neurocrine Biosciences (NBIX) Is Spiking Today
2014-01-07,Heavy Trading On Neurocrine Biosciences (NBIX) Before Market Open
2014-01-02,First Week Of August 16th Options Trading For Neurocrine Biosciences (NBIX)
2013-12-04,Neurocrine Biosciences To Present At Oppenheimer's 24th Annual Healthcare Conference
2013-11-26,Neurocrine Biosciences To Present At Deutsche Bank 2013 Biofest And The 25th Annual Piper Jaffray Healthcare Conference
2013-10-31,December 2014 Options Now Available For Neurocrine Biosciences (NBIX)
2013-10-28,Interesting NBIX Put And Call Options For December 21st
2013-10-22,Neurocrine Biosciences Announces Conference Call And Webcast To Present Third Quarter 2013 Financial Results
2013-10-07,January 2015 Options Now Available For Neurocrine Biosciences (NBIX)
2013-10-04,5 Stocks Poised for Breakouts
2013-09-26,First Week Of NBIX May 2014 Options Trading
2013-09-13,Neurocrine Biosciences Becomes Oversold (NBIX)
2013-09-10,4 Stocks Dragging In The Drugs Industry
2013-09-03,Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
2013-08-29,Neurocrine Biosciences Announces The Start Of Second Phase III Study Of Elagolix In Endometriosis
2013-08-22,5 Stocks Spiking on Unusual Volume
2013-07-18,Neurocrine Biosciences Announces Conference Call And Webcast To Present Second Quarter 2013 Financial Results
2013-07-03,Interesting NBIX Put And Call For September 21st
2013-07-01,Neurocrine Announces Completion Of Enrollment Into Kinect Study For Treatment Of Tardive Dyskinesia
2013-05-30,'Mad Money' Lightning Round: Hold on to Sprint
2013-05-29,Cramer's 'Mad Money' Recap: Stop Being Complacent
2013-05-29,Neurocrine Biosciences To Present At The Jefferies 2013 Global Healthcare Conference
2013-05-24,Commit To Buy Neurocrine Biosciences At $9, Earn 28.8% Annualized
